On ECHEMI
Home > Drugs > Suzhou Pharmaceutical Factory
Suzhou Pharmaceutical Factory
  • Founded in:

    2006-02-14
  • Country:

    China China
  • Address:

    No. 2-1, Dongwu South Road, Wuzhong District, Suzhou City
  • Tax NO.:

    91320506138170408U
  • Registered Funds:

    -
  • Website:

  • Email:

Related Drugs
Methocarbamol Injection
Name Description Content CAS NO. Registered Holders
Methocarbamol

Extract from the above information

More

Extract from the above information

532-03-6 31
Methocarbamol Injection
Name Description Content CAS NO. Registered Holders
Methocarbamol

Muscle relaxant effect

More

Muscle relaxant effect

532-03-6 31
Vitamin D3 Injection
The main ingredient of this product is vitamin D3.
Name Description Content CAS NO. Registered Holders
Vitamin D3

This product is a vitamin drug. Vitamin D2 promotes the absorption of calcium by the brush border of the small intestinal mucosa and the reabsorption of phosphorus by the renal tubules, increases the concentration of blood calcium and phosphorus, cooperates with parathyroid hormone and calcitonin, promotes the release of calcium phosphate from old bones, and maintains and regulates the normal concentration of plasma calcium and phosphorus. Vitamin D2 promotes the deposition of calcium in the new bone formation site, deposits citrate in the bone, promotes bone calcification and the maturation of osteoblast function and bone-like tissue. After vitamin D2 is ingested, it is catalyzed by the 25-hydroxylase system in the cell microsomes to generate calcidiol (25-OHD3), which is catalyzed by the 1-hydroxylase system of the renal proximal tubular cells to generate biologically active calcitriol [1-25-(OH)2D3].

More

This product is a vitamin drug. Vitamin D2 promotes the absorption of calcium by the brush border of the small intestinal mucosa and the reabsorption of phosphorus by the renal tubules, increases the concentration of blood calcium and phosphorus, cooperates with parathyroid hormone and calcitonin, promotes the release of calcium phosphate from old bones, and maintains and regulates the normal concentration of plasma calcium and phosphorus. Vitamin D2 promotes the deposition of calcium in the new bone formation site, deposits citrate in the bone, promotes bone calcification and the maturation of osteoblast function and bone-like tissue. After vitamin D2 is ingested, it is catalyzed by the 25-hydroxylase system in the cell microsomes to generate calcidiol (25-OHD3), which is catalyzed by the 1-hydroxylase system of the renal proximal tubular cells to generate biologically active calcitriol [1-25-(OH)2D3].

67-97-0 23
Mycophenolate Mofetil for Injection
Mycophenolate mofetil
Name Description Content CAS NO. Registered Holders
Mycophenolate mofetil

No specific description provided

More

No specific description provided

115007-34-6 54
Potassium Magnesium Aspartate Oral Solution
This product is an aqueous solution of L-aspartic acid, magnesium oxide and potassium hydroxide. The content of aspartic acid (C4H7NO4), potassium (K) and magnesium (Mg) should be 90.0-110.0% of the labeled amount.
Name Description Content CAS NO. Registered Holders
L-ASPARTIC ACID

Aspartic acid is the precursor of oxaloacetate and plays an important role in the tricarboxylic acid cycle, ornithine cycle and nucleotide synthesis. It has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability and internal environment stability of cells such as nerve tissue, myocardium and smooth muscle. It participates in the ornithine cycle, promotes urea production and reduces ammonia in the blood.

More

Aspartic acid is the precursor of oxaloacetate and plays an important role in the tricarboxylic acid cycle, ornithine cycle and nucleotide synthesis. It has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability and internal environment stability of cells such as nerve tissue, myocardium and smooth muscle. It participates in the ornithine cycle, promotes urea production and reduces ammonia in the blood.

6899-03-2 18
Potassium

It transports electrolytes to the myocardium, promotes muscle cell depolarization, maintains myocardial contractility, and reduces myocardial oxygen consumption. It has a protective effect on the myocardium when coronary circulation disorders cause hypoxia.

More

It transports electrolytes to the myocardium, promotes muscle cell depolarization, maintains myocardial contractility, and reduces myocardial oxygen consumption. It has a protective effect on the myocardium when coronary circulation disorders cause hypoxia.

0
Magnesium

It transports electrolytes to the myocardium, promotes muscle cell depolarization, maintains myocardial contractility, and reduces myocardial oxygen consumption. It has a protective effect on the myocardium when coronary circulation disorders cause hypoxia.

More

It transports electrolytes to the myocardium, promotes muscle cell depolarization, maintains myocardial contractility, and reduces myocardial oxygen consumption. It has a protective effect on the myocardium when coronary circulation disorders cause hypoxia.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.